Cargando…

Risk factor analysis of intravesical recurrence after retroperitoneoscopic nephroureterectomy for upper tract urothelial carcinoma

BACKGROUND: One of the major concerns of patients with upper tract urothelial carcinoma (UTUC) treated with nephroureterectomy is intravesical recurrence (IVR). The purpose of the present study was to investigate the predictive risk factors for IVR after retroperitoneoscopic nephroureterectomy (RNU)...

Descripción completa

Detalles Bibliográficos
Autores principales: Yanagi, Masato, Hamasaki, Tsutomu, Akatsuka, Jun, Endo, Yuki, Takeda, Hayato, Kondo, Yukihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638342/
https://www.ncbi.nlm.nih.gov/pubmed/34856960
http://dx.doi.org/10.1186/s12894-021-00932-2
_version_ 1784608933678153728
author Yanagi, Masato
Hamasaki, Tsutomu
Akatsuka, Jun
Endo, Yuki
Takeda, Hayato
Kondo, Yukihiro
author_facet Yanagi, Masato
Hamasaki, Tsutomu
Akatsuka, Jun
Endo, Yuki
Takeda, Hayato
Kondo, Yukihiro
author_sort Yanagi, Masato
collection PubMed
description BACKGROUND: One of the major concerns of patients with upper tract urothelial carcinoma (UTUC) treated with nephroureterectomy is intravesical recurrence (IVR). The purpose of the present study was to investigate the predictive risk factors for IVR after retroperitoneoscopic nephroureterectomy (RNU) for UTUC. METHODS: Clinicopathological and surgical information were collected from the medical records of 73 patients treated with RNU for non-metastatic UTUC, without a history of or concomitant bladder cancer. The association between IVR after RNU and clinicopathological and surgery-related factors, including preoperative urine cytology and pneumoretroperitoneum time, was analyzed using the Fisher exact test. RESULTS: During the median follow-up time of 39.1 months, 18 (24.7%) patients had subsequent IVR after RNU. The 1- and 3-year IVR-free survival rates were 85.9% and 76.5%, respectively. The Fisher exact test revealed that prolonged pneumoretroperitoneum time of ≥ 210 min was a risk factor for IVR in 1 year after RNU (p = 0.0358) and positive urine cytology was a risk factor for IVR in 3 years after RNU (p = 0.0352). CONCLUSIONS: In UTUC, the occurrences of IVR in 1 and 3 years after RNU are highly probable when the pneumoretroperitoneum time is prolonged (≥ 210 min) and in patients with positive urine cytology, respectively. Strict follow-up after RNU is more probable recommended for these patients.
format Online
Article
Text
id pubmed-8638342
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86383422021-12-02 Risk factor analysis of intravesical recurrence after retroperitoneoscopic nephroureterectomy for upper tract urothelial carcinoma Yanagi, Masato Hamasaki, Tsutomu Akatsuka, Jun Endo, Yuki Takeda, Hayato Kondo, Yukihiro BMC Urol Research BACKGROUND: One of the major concerns of patients with upper tract urothelial carcinoma (UTUC) treated with nephroureterectomy is intravesical recurrence (IVR). The purpose of the present study was to investigate the predictive risk factors for IVR after retroperitoneoscopic nephroureterectomy (RNU) for UTUC. METHODS: Clinicopathological and surgical information were collected from the medical records of 73 patients treated with RNU for non-metastatic UTUC, without a history of or concomitant bladder cancer. The association between IVR after RNU and clinicopathological and surgery-related factors, including preoperative urine cytology and pneumoretroperitoneum time, was analyzed using the Fisher exact test. RESULTS: During the median follow-up time of 39.1 months, 18 (24.7%) patients had subsequent IVR after RNU. The 1- and 3-year IVR-free survival rates were 85.9% and 76.5%, respectively. The Fisher exact test revealed that prolonged pneumoretroperitoneum time of ≥ 210 min was a risk factor for IVR in 1 year after RNU (p = 0.0358) and positive urine cytology was a risk factor for IVR in 3 years after RNU (p = 0.0352). CONCLUSIONS: In UTUC, the occurrences of IVR in 1 and 3 years after RNU are highly probable when the pneumoretroperitoneum time is prolonged (≥ 210 min) and in patients with positive urine cytology, respectively. Strict follow-up after RNU is more probable recommended for these patients. BioMed Central 2021-12-02 /pmc/articles/PMC8638342/ /pubmed/34856960 http://dx.doi.org/10.1186/s12894-021-00932-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Yanagi, Masato
Hamasaki, Tsutomu
Akatsuka, Jun
Endo, Yuki
Takeda, Hayato
Kondo, Yukihiro
Risk factor analysis of intravesical recurrence after retroperitoneoscopic nephroureterectomy for upper tract urothelial carcinoma
title Risk factor analysis of intravesical recurrence after retroperitoneoscopic nephroureterectomy for upper tract urothelial carcinoma
title_full Risk factor analysis of intravesical recurrence after retroperitoneoscopic nephroureterectomy for upper tract urothelial carcinoma
title_fullStr Risk factor analysis of intravesical recurrence after retroperitoneoscopic nephroureterectomy for upper tract urothelial carcinoma
title_full_unstemmed Risk factor analysis of intravesical recurrence after retroperitoneoscopic nephroureterectomy for upper tract urothelial carcinoma
title_short Risk factor analysis of intravesical recurrence after retroperitoneoscopic nephroureterectomy for upper tract urothelial carcinoma
title_sort risk factor analysis of intravesical recurrence after retroperitoneoscopic nephroureterectomy for upper tract urothelial carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638342/
https://www.ncbi.nlm.nih.gov/pubmed/34856960
http://dx.doi.org/10.1186/s12894-021-00932-2
work_keys_str_mv AT yanagimasato riskfactoranalysisofintravesicalrecurrenceafterretroperitoneoscopicnephroureterectomyforuppertracturothelialcarcinoma
AT hamasakitsutomu riskfactoranalysisofintravesicalrecurrenceafterretroperitoneoscopicnephroureterectomyforuppertracturothelialcarcinoma
AT akatsukajun riskfactoranalysisofintravesicalrecurrenceafterretroperitoneoscopicnephroureterectomyforuppertracturothelialcarcinoma
AT endoyuki riskfactoranalysisofintravesicalrecurrenceafterretroperitoneoscopicnephroureterectomyforuppertracturothelialcarcinoma
AT takedahayato riskfactoranalysisofintravesicalrecurrenceafterretroperitoneoscopicnephroureterectomyforuppertracturothelialcarcinoma
AT kondoyukihiro riskfactoranalysisofintravesicalrecurrenceafterretroperitoneoscopicnephroureterectomyforuppertracturothelialcarcinoma